Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces three upcoming presentations at the ...
Businesses are no longer just competing on product, price, or service but on their ability to navigate and leverage these ...
Adverse childhood experiences and traumatic events experienced or witnessed at any point during one's lifetime can sometimes ...
Metabolic dysfunction may be more than a comorbidity in bipolar disorder—it could be a key driver of disease progression and ...
The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...
As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...
By growing miniature brain models from patient cells, researchers have identified distinct electrical activity patterns ...
Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...
AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...
NEW YORK, March 23, 2026 /PRNewswire/ -- Production Resource Group ("PRG" or "the Company"), a leading global provider of ...
Researchers uncover how SMAD7 directly activates Wnt signaling to promote dental pulp stem cell regeneration CHINA, ...
Discusses Accelerating Generative AI Adoption in Telecom With Purpose-Built Agentic Operating System March 23, 2026 2:00 PM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results